In vivo gene silencing of CD81 by lentiviral expression of small interference RNAs suppresses cocaine-induced behaviour

Journal of Neurochemistry

Volumn 92, Issue 5, 2005, Pages 1243-1255

  Bahi, Amine ^a   Boyer, Frederic ^a   Kolira, Manoj ^a   Dreyer, Jean Luc ^a  

^a UNIVERSITY OF FRIBOURG   (Switzerland)

Author keywords

Addiction; Gene knock down; in vivo gene transfer; Lentivirus; Plasticity; Small interference RNA

Indexed keywords

CD81 ANTIGEN; COCAINE; LENTIVIRUS VECTOR; SMALL INTERFERING RNA;

ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL STRAIN HEK293; COCAINE DEPENDENCE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; EMBRYO; GENE CONTROL; GENE EXPRESSION; GENE INDUCTION; GENE SILENCING; GENE TARGETING; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIMBIC CORTEX; LOCOMOTION; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; NUCLEUS ACCUMBENS; PRIORITY JOURNAL; PROMOTER REGION; RAT; REAL TIME POLYMERASE CHAIN REACTION; VENTRAL TEGMENTUM;

ANESTHETICS, LOCAL; ANIMALS; ANTIGENS, CD; BEHAVIOR, ANIMAL; BLOTTING, NORTHERN; CELL COUNT; CELL LINE; COCAINE; COCAINE-RELATED DISORDERS; DRUG INTERACTIONS; GENE EXPRESSION REGULATION; GENE SILENCING; GENETIC VECTORS; HUMANS; IMMUNOHISTOCHEMISTRY; LENTIVIRUS; MALE; MOTOR ACTIVITY; NUCLEUS ACCUMBENS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL INTERFERING; TRANSFECTION; VENTRAL TEGMENTAL AREA;

LENTIVIRUS;

EID: 14844283156     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02961.x     Document Type: Article

References (56)

1. Bahi A. and Dreyer J. L. (2005) Cocaine-induced expression changes of axon guidance molecules in the adult rat brain. Mol. Cell Neurosci. 28, 275-291.
2. Bahi A., Boyer F., Kafri T. and Dreyer J. L. (2004) CD81-induced behavioural changes during chronic cocaine administration. In vivo gene delivery with regulatable Lentivirus. Eur. J. Neurosci. 19, 1621-1633.
3. Banerjee S. A., Hadjiargyrou M. and Patterson P. H. (1997) An antibody to the tetraspan membrane protein CD9 promotes neurite formation in a partially alpha3beta1 integrin-dependent manner. J. Neurosci. 17, 2756-2765.
4. Beckman C., Zhang Y., Hoffer B. J. and Tomac A. C. (2003) Short interfering RNAs (siRNAs) for reducing dopaminergic phenotypic markers. J. Neurosci. Meth. 131, 51-56.
5. Berditchevski F., Tolias K. F., Wong K., Carpenter C. L. and Hemler M. E. (1997) A novel link between integrins, transmembrane-4-superfamily proteins (CD63 and CD81) and phosphatidyl-inositol-4-kinase. J. Biol. Chem. 272, 2595-2598.
6. Brenz-Verca M. S., Widmer D. A. J., Wagner G. C. and Dreyer J. L. (2001) Cocaine-induced expression of the tetraspanin CD81 and its relation to hypothalamic function. Mol. Cell Neurosci. 17, 303-316.
7. Brummelkamp T. R., Bernards R. and Agami R. (2002) Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2, 243-247.
8. Carloni V., Mazzocca A. and Ravichandran K. S. (2004) Tetraspanin CD81 is linked to ERK/MAPKinase signaling by Shc in liver tumor cells. Oncogene 23, 1566-1574.
9. Carmo A. M. and Wright M. D. (1995) Association of the transmembrane 4 superfamily molecule CD53 with a tyrosine phosphatase activity. Eur. J. Immunol. 25, 2090-2095.
10. Charrin S., Le Naour F., Oualid M., Billard M., Faure G., Hanash S. M., Boucheix C. and Rubinstein E. (2001) The major CD9 and CD81 molecular partner. Identification and characterization of the complexes. J. Biol. Chem. 176, 14 329-14 337.
11. Davidson B. L. and Paulson H. L. (2004) Molecular medicine for the brain: silencing of disease genes with RNA interference. Lancet 3, 145-149.
12. Desai C. J., Sun Q. and Zinn K. (1997) Tyrosine phosphorylation and axon guidance: of mice and flies. Curr. Opin. Neurobiol. 7, 70-74.
13. Devroe E. and Silver P. A. (2004) Therapeutic potential of retroviral RNAi vectors. Exp. Opin. Biol. Ther. 4, 319-327.
14. Dorn G., Patel S., Wotherspoon G. et al. (2004) siRNA relieves chronic neuropathic pain. Nucl. Acids Res. 32, 1-6.
15. Filleur S., Courtin A., Ait-Si-Ali S., Guglielmi J., Merle C., Harel-Bellan A., Clezardin P. and Cabon F. (2003) siRNA-mediated inhibition of vascular endothelial growth factor severely limits tumor resistance to anti-angiogenic thrombospondin-1 and slows tumor vascularization and growth. Cancer Res. 63, 3919-3922.
16. Fradkin L. G., Kamphorst J. T., DiAntonio A., Goodman C. S. and Noordermeer J. N. (2002) Genome-wide analysis of the Drosophila tetraspanins reveals a subset with similar function in the formation of the embryonic synapse. Proc. Natl Acad. Sci. USA 99, 13 663-13 668.
17. Haack K., Cockrell A. S., Ma H., Israeli D., Ho S. N., McCown T. J. and Kafri T. (2004) Transactivator and structurally optimized inducible lentiviral vectors. Mol. Ther. 10, 585-596.
18. Halladay A. K., Yue Y., Michna L., Widmer D. A. J., Wagner G. C. and Zhou R. (2000) Regulation of EphB1 expression by dopamine signaling. Mol. Brain Res. 85, 171-178.
19. Hemler M. E. (1998) Integrin associated proteins. Curr. Opin. Cell Biol. 10, 578-585.
20. Holen T., Amarzguioui M., Wiiger M. T., Babaie E. and Prydz H. (2002) Positional effects of short interfering RNAs targeting the human coagulation trigger Tissue Factor. Nucl. Acids Res. 30, 1757-1766.
21. Ishibashi T., Ding L., Ikenaka K., Inoue Y., Miyado K., Mekada E. and Baba H. (2004) Tetraspanin protein CD9 is a novel paranodal component regulating paranodal junctional formation. J. Neurosci. 24, 96-102.
22. Jackson A. L., Bartz S. R., Schelter J., Kobayashi S. V., Burchard J., Mao M., Li B., Cavet G. and Linsley P. S. (2003) Expression profiling reveals off-target gene regulation by RNAi. Nat. Biotechnol. 21, 635-637.
23. Jacque J. M., Triques K. and Stevenson M. (2002) Modulation of HIV-1 replication by RNA interference. Nature 418, 435-438.
24. Jain K. K. (2004) RNAi and siRNA in target validation. Drug Discov. Today 9, 307-309.
25. Kafri T., van Praag H., Gage F. H. and Verma I. M. (2000) Lentiviral vectors: regulated gene expression. Mol. Ther. 1, 516-521.
26. Kelic S., Levy S., Suarez C. and Weinstein D. E. (2001) CD81 regulates neuron-induced astrocyte cell-cycle exit. Mol. Cell. Neurosci. 17, 551-560.
27. Keynes R. and Cook G. M. (1995) Axon guidance molecules. Cell 83, 161-169.
28. Kong X. C., Barzaghi P. and Ruegg M. A. (2003) Inhibition of synapse assembly in mammalian muscle in vivo by RNA interference. EMBO Reports 5, 1-6.
29. Little K. D., Hemler M. E. and Stipp C. S. (2004) Dynamic regulation of GPCR-tetraspanin-G protein complex on intact cells: central role of CD81 in facilitating GPR56-Gaq/11 association: Mol. Biol. Cell 15, 2375-2387.
30. Makimura H., Mizuno T. M., Mastaitis J. W., Agami R. and Mobbs C. V. (2002) Reducing hypothalamic AGRP by RNA interference increases metabolic rate and decreases body weight without influencing food intake. BMC Neurosci. 3, 18-24.
31. McCaffrey A. P., Nakai H., Pandey K., Huang Z., Salazar F. H., Xu H., Wieland S. F., Marion P. L. and Kay M. A. (2003) Inhibition of hepatitis B virus in mice by RNA interference. Nat. Biotechnol. 21, 639-644.
32. Michna L., Brenz Verca M. S., Widmer D. A. J., Chen S. L., Rogrove J., Zhou R., Tsitsikov E., Miescher G. C. J.-L., Dreyer J. L. and Wagner G. C. (2001) Altered sensitivity of CD81-deficient mice to neurobehavioural effects of cocaine. Mol. Brain Res. 90, 68-74.
33. Mourelatos Z., Dostie J., Paushkin S., Sharma A., Charroux B., Abel L., Rappsilber J., Mann M. and Dreyfuss G. (2002) miRNAPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev. 16, 720-728.
34. Mühlbauer M., Allard B., Bosserhoff A. K., Kiessling S., Herfarth H., Regler G., Schölmerich J., Jobin C. and Hellerbrand C. (2004) Differential effects of deoxycholic acid and taurodeoxycholic acid on NF{kappa}B signal transduction and IL-8 gene expression in colonic epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 286, 1000-1008.
35. Naldini L., Blomer U., Gallay P., Ory D., Mulligan R., Gage F. H., Verma I. M. and Trono D. (1996) In vivo gene delivery and stable transduction of non-dividing cells by a lentiviral vector. Science 272, 263-267.
36. Nestler E. J. (2000) Genes and addiction. Nat. Genet. 26, 277-281.
37. Okabe C. and Murphy N. P. (2004) Short-term effects of the nociceptin receptor antagonist Compound B on the development of methamphetamine sensitization in mice: a behavioral and c-fos expression mapping study. Brain Res. 1017, 1-12.
38. Podhorna J. and Didriksen M. (2004) The heterozygous reeler mouse: behavioural phenotype. Behav. Brain Res. 153, 43-54.
39. Reiser J., Lai Z., Zhang X. Y. and Brady R. O. (2000) Development of multigene and regulated lentivirus vectors. J. Virol. 74, 10 589-10 599.
40. Robinson T. E. and Berridge K. C. (1993) The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res. Brain Res. Rev. 18, 247-291.
41. Robinson D. A., Dillon C. P., Kwiatkowski A. V. et al. (2003) A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet. 33, 401-406.
42. Sanchis-Segura C., Pastor R. and Aragon C. M. (2004) Opposite effects of acute versus chronic naltrexone administration on ethanol-induced locomotion. Behav. Brain Res. 153, 61-67.
43. Schmidt C., Kunemund V., Wintergerst E. S., Schmitz B. and Schachner M. (1996) CD9 of mouse brain is implicated in neurite outgrowth and cell migration in vitro and is associated with the alpha 6/beta 1 integrin and the neural adhesion molecule L1. J. Neurosci. Res. 43, 12-31.
44. Semizarov D., Frost L., Sarthy A., Kroeger P., Halbert D. N. and Fesik S. W. (2003) Specificity of short interfering RNA determined through gene expression signatures. Proc. Natl Acad. Sci. USA 100, 6347-6352.
45. Shi Y. (2004) Mammalian RNAi for the masses. Trends Genet. 19, 9-12.
46. Song E., Lee S. K., Wang J., Ince N., Ouyang N., Min J., Chen J., Shankar P. and Lieberman J. (2003) RNA interference targeting Fas protects mice from fulminant hepatitis. Nat. Med. 9, 347-351.
47. Sorensen D. R., Leirdal M. and Sioud M. (2003.) Gene silencing by systemic delivery of synthetic siRNAs in adult mice. J. Mol. Biol. 327, 761-766.
48. Stipp C. S., Kolesnikova T. V. and Hemler M. E. (2003) EWI-2 regulates α3β1 integrin-dependent cell function on laminin-5. J. Cell Biol. 163, 1167-1177.
49. Stipp D. C., Kolesnikova T. V. and Hemler M. E. (2001) EWI-2 is a major CD9 and CD81 partner and member of a novel Ig protein subfamily. J. Biol. Chem. 276, 40 545-40 554.
50. Terada N., Baracskay K., Kinter M., Melrose S., Brophy P. J., Boucheix C., Bjartmar C., Kidd G. and Trapp B. D. (2002) The Tetraspanin protein, CD9, is expressed by progenitor cells committed to oligodendrogenesis and is linked to β1 integrin, CD81, and Tspan-2. Glia 40, 350-359.
51. Usman N. (2004) From target validation to therapeutics with RNAi. Curr. Drug Discov. 4, 15-19.
52. Verma U. N., Surabhi R. M., Schmaltieg A., Becerra C. and Gaynor R. B. (2003) Small interfering RNAs directed against beta-catenin inhibit the in vitro and in vivo growth of colon cancer cells. Clin. Cancer Res. 9, 1291-1300.
53. Yokota T., Sakamoto N., Enomoto N. et al. (2003) Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO Rep. 4, 602-608.
54. Yue Y., Chen Z. Y., Gale N. W. et al. (2002) Mistargeting hippocampal axons by expression of a truncated Eph receptor. Proc. Natl Acad. Sci. USA 99, 10 777-10 782.
55. Zender L., Hutker S., Liedtke C. et al. (2003) Caspase 8 small interfering RNA prevents acute liver failure in mice. Proc. Natl Acad. Sci. USA 100, 7797-7802.
56. Zhang M., McManus M. T., Gertler F. B., Scott M. L. and Van Parijs L. (2003) A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat. Genet 33, 401-406.